Global Basiliximab Injection Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Basiliximab Injection is used with other medications to prevent immediate transplant rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in people who are receiving kidney transplants. Basiliximab injection is in a class of medications called immunosuppressants. It works by decreasing the activity of the body's immune system so it will not attack the transplanted organ.
LPI (LP Information)' newest research report, the “Basiliximab Injection Industry Forecast” looks at past sales and reviews total world Basiliximab Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Basiliximab Injection sales for 2023 through 2029. With Basiliximab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Basiliximab Injection industry.
This Insight Report provides a comprehensive analysis of the global Basiliximab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Basiliximab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Basiliximab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Basiliximab Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Basiliximab Injection.
The global Basiliximab Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Basiliximab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Basiliximab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Basiliximab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Basiliximab Injection players cover Novartis AG and Ryvis Pharma etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Basiliximab Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Basiliximab Injection market?
What factors are driving Basiliximab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Basiliximab Injection market opportunities vary by end market size?
How does Basiliximab Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Basiliximab Injection is used with other medications to prevent immediate transplant rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in people who are receiving kidney transplants. Basiliximab injection is in a class of medications called immunosuppressants. It works by decreasing the activity of the body's immune system so it will not attack the transplanted organ.
LPI (LP Information)' newest research report, the “Basiliximab Injection Industry Forecast” looks at past sales and reviews total world Basiliximab Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Basiliximab Injection sales for 2023 through 2029. With Basiliximab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Basiliximab Injection industry.
This Insight Report provides a comprehensive analysis of the global Basiliximab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Basiliximab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Basiliximab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Basiliximab Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Basiliximab Injection.
The global Basiliximab Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Basiliximab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Basiliximab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Basiliximab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Basiliximab Injection players cover Novartis AG and Ryvis Pharma etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Basiliximab Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 20 mL
- 10 mL
- Adult Use
- Pediatric Use
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis AG
- Ryvis Pharma
What is the 10-year outlook for the global Basiliximab Injection market?
What factors are driving Basiliximab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Basiliximab Injection market opportunities vary by end market size?
How does Basiliximab Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Basiliximab Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Basiliximab Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Basiliximab Injection by Country/Region, 2018, 2022 & 2029
2.2 Basiliximab Injection Segment by Type
2.2.1 20 mL
2.2.2 10 mL
2.3 Basiliximab Injection Sales by Type
2.3.1 Global Basiliximab Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Basiliximab Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Basiliximab Injection Sale Price by Type (2018-2023)
2.4 Basiliximab Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.5 Basiliximab Injection Sales by Application
2.5.1 Global Basiliximab Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Basiliximab Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Basiliximab Injection Sale Price by Application (2018-2023)
3 GLOBAL BASILIXIMAB INJECTION BY COMPANY
3.1 Global Basiliximab Injection Breakdown Data by Company
3.1.1 Global Basiliximab Injection Annual Sales by Company (2018-2023)
3.1.2 Global Basiliximab Injection Sales Market Share by Company (2018-2023)
3.2 Global Basiliximab Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Basiliximab Injection Revenue by Company (2018-2023)
3.2.2 Global Basiliximab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Basiliximab Injection Sale Price by Company
3.4 Key Manufacturers Basiliximab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Basiliximab Injection Product Location Distribution
3.4.2 Players Basiliximab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BASILIXIMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Basiliximab Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Basiliximab Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Basiliximab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Basiliximab Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Basiliximab Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Basiliximab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Basiliximab Injection Sales Growth
4.4 APAC Basiliximab Injection Sales Growth
4.5 Europe Basiliximab Injection Sales Growth
4.6 Middle East & Africa Basiliximab Injection Sales Growth
5 AMERICAS
5.1 Americas Basiliximab Injection Sales by Country
5.1.1 Americas Basiliximab Injection Sales by Country (2018-2023)
5.1.2 Americas Basiliximab Injection Revenue by Country (2018-2023)
5.2 Americas Basiliximab Injection Sales by Type
5.3 Americas Basiliximab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Basiliximab Injection Sales by Region
6.1.1 APAC Basiliximab Injection Sales by Region (2018-2023)
6.1.2 APAC Basiliximab Injection Revenue by Region (2018-2023)
6.2 APAC Basiliximab Injection Sales by Type
6.3 APAC Basiliximab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Basiliximab Injection by Country
7.1.1 Europe Basiliximab Injection Sales by Country (2018-2023)
7.1.2 Europe Basiliximab Injection Revenue by Country (2018-2023)
7.2 Europe Basiliximab Injection Sales by Type
7.3 Europe Basiliximab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Basiliximab Injection by Country
8.1.1 Middle East & Africa Basiliximab Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Basiliximab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Basiliximab Injection Sales by Type
8.3 Middle East & Africa Basiliximab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Basiliximab Injection
10.3 Manufacturing Process Analysis of Basiliximab Injection
10.4 Industry Chain Structure of Basiliximab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Basiliximab Injection Distributors
11.3 Basiliximab Injection Customer
12 WORLD FORECAST REVIEW FOR BASILIXIMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Basiliximab Injection Market Size Forecast by Region
12.1.1 Global Basiliximab Injection Forecast by Region (2024-2029)
12.1.2 Global Basiliximab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Basiliximab Injection Forecast by Type
12.7 Global Basiliximab Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Basiliximab Injection Product Portfolios and Specifications
13.1.3 Novartis AG Basiliximab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Basiliximab Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Basiliximab Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Basiliximab Injection by Country/Region, 2018, 2022 & 2029
2.2 Basiliximab Injection Segment by Type
2.2.1 20 mL
2.2.2 10 mL
2.3 Basiliximab Injection Sales by Type
2.3.1 Global Basiliximab Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Basiliximab Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Basiliximab Injection Sale Price by Type (2018-2023)
2.4 Basiliximab Injection Segment by Application
2.4.1 Adult Use
2.4.2 Pediatric Use
2.5 Basiliximab Injection Sales by Application
2.5.1 Global Basiliximab Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Basiliximab Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Basiliximab Injection Sale Price by Application (2018-2023)
3 GLOBAL BASILIXIMAB INJECTION BY COMPANY
3.1 Global Basiliximab Injection Breakdown Data by Company
3.1.1 Global Basiliximab Injection Annual Sales by Company (2018-2023)
3.1.2 Global Basiliximab Injection Sales Market Share by Company (2018-2023)
3.2 Global Basiliximab Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Basiliximab Injection Revenue by Company (2018-2023)
3.2.2 Global Basiliximab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Basiliximab Injection Sale Price by Company
3.4 Key Manufacturers Basiliximab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Basiliximab Injection Product Location Distribution
3.4.2 Players Basiliximab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BASILIXIMAB INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Basiliximab Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Basiliximab Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Basiliximab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Basiliximab Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Basiliximab Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Basiliximab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Basiliximab Injection Sales Growth
4.4 APAC Basiliximab Injection Sales Growth
4.5 Europe Basiliximab Injection Sales Growth
4.6 Middle East & Africa Basiliximab Injection Sales Growth
5 AMERICAS
5.1 Americas Basiliximab Injection Sales by Country
5.1.1 Americas Basiliximab Injection Sales by Country (2018-2023)
5.1.2 Americas Basiliximab Injection Revenue by Country (2018-2023)
5.2 Americas Basiliximab Injection Sales by Type
5.3 Americas Basiliximab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Basiliximab Injection Sales by Region
6.1.1 APAC Basiliximab Injection Sales by Region (2018-2023)
6.1.2 APAC Basiliximab Injection Revenue by Region (2018-2023)
6.2 APAC Basiliximab Injection Sales by Type
6.3 APAC Basiliximab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Basiliximab Injection by Country
7.1.1 Europe Basiliximab Injection Sales by Country (2018-2023)
7.1.2 Europe Basiliximab Injection Revenue by Country (2018-2023)
7.2 Europe Basiliximab Injection Sales by Type
7.3 Europe Basiliximab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Basiliximab Injection by Country
8.1.1 Middle East & Africa Basiliximab Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Basiliximab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Basiliximab Injection Sales by Type
8.3 Middle East & Africa Basiliximab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Basiliximab Injection
10.3 Manufacturing Process Analysis of Basiliximab Injection
10.4 Industry Chain Structure of Basiliximab Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Basiliximab Injection Distributors
11.3 Basiliximab Injection Customer
12 WORLD FORECAST REVIEW FOR BASILIXIMAB INJECTION BY GEOGRAPHIC REGION
12.1 Global Basiliximab Injection Market Size Forecast by Region
12.1.1 Global Basiliximab Injection Forecast by Region (2024-2029)
12.1.2 Global Basiliximab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Basiliximab Injection Forecast by Type
12.7 Global Basiliximab Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Basiliximab Injection Product Portfolios and Specifications
13.1.3 Novartis AG Basiliximab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Basiliximab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Basiliximab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 20 mL
Table 4. Major Players of 10 mL
Table 5. Global Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 6. Global Basiliximab Injection Sales Market Share by Type (2018-2023)
Table 7. Global Basiliximab Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Basiliximab Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Basiliximab Injection Sale Price by Type (2018-2023) & (US$/L)
Table 10. Global Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 11. Global Basiliximab Injection Sales Market Share by Application (2018-2023)
Table 12. Global Basiliximab Injection Revenue by Application (2018-2023)
Table 13. Global Basiliximab Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Basiliximab Injection Sale Price by Application (2018-2023) & (US$/L)
Table 15. Global Basiliximab Injection Sales by Company (2018-2023) & (KL)
Table 16. Global Basiliximab Injection Sales Market Share by Company (2018-2023)
Table 17. Global Basiliximab Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Basiliximab Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Basiliximab Injection Sale Price by Company (2018-2023) & (US$/L)
Table 20. Key Manufacturers Basiliximab Injection Producing Area Distribution and Sales Area
Table 21. Players Basiliximab Injection Products Offered
Table 22. Basiliximab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Basiliximab Injection Sales by Geographic Region (2018-2023) & (KL)
Table 26. Global Basiliximab Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Basiliximab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Basiliximab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Basiliximab Injection Sales by Country/Region (2018-2023) & (KL)
Table 30. Global Basiliximab Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Basiliximab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Basiliximab Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Basiliximab Injection Sales by Country (2018-2023) & (KL)
Table 34. Americas Basiliximab Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Basiliximab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Basiliximab Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 38. Americas Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 39. APAC Basiliximab Injection Sales by Region (2018-2023) & (KL)
Table 40. APAC Basiliximab Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Basiliximab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Basiliximab Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 44. APAC Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 45. Europe Basiliximab Injection Sales by Country (2018-2023) & (KL)
Table 46. Europe Basiliximab Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Basiliximab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Basiliximab Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 50. Europe Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 51. Middle East & Africa Basiliximab Injection Sales by Country (2018-2023) & (KL)
Table 52. Middle East & Africa Basiliximab Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Basiliximab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Basiliximab Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 56. Middle East & Africa Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 57. Key Market Drivers & Growth Opportunities of Basiliximab Injection
Table 58. Key Market Challenges & Risks of Basiliximab Injection
Table 59. Key Industry Trends of Basiliximab Injection
Table 60. Basiliximab Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Basiliximab Injection Distributors List
Table 63. Basiliximab Injection Customer List
Table 64. Global Basiliximab Injection Sales Forecast by Region (2024-2029) & (KL)
Table 65. Global Basiliximab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Basiliximab Injection Sales Forecast by Country (2024-2029) & (KL)
Table 67. Americas Basiliximab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Basiliximab Injection Sales Forecast by Region (2024-2029) & (KL)
Table 69. APAC Basiliximab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Basiliximab Injection Sales Forecast by Country (2024-2029) & (KL)
Table 71. Europe Basiliximab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Basiliximab Injection Sales Forecast by Country (2024-2029) & (KL)
Table 73. Middle East & Africa Basiliximab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Basiliximab Injection Sales Forecast by Type (2024-2029) & (KL)
Table 75. Global Basiliximab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Basiliximab Injection Sales Forecast by Application (2024-2029) & (KL)
Table 77. Global Basiliximab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis AG Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis AG Basiliximab Injection Product Portfolios and Specifications
Table 80. Novartis AG Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 81. Novartis AG Main Business
Table 82. Novartis AG Latest Developments
Table 83. Ryvis Pharma Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Ryvis Pharma Basiliximab Injection Product Portfolios and Specifications
Table 85. Ryvis Pharma Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 86. Ryvis Pharma Main Business
Table 87. Ryvis Pharma Latest Developments
Table 1. Basiliximab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Basiliximab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 20 mL
Table 4. Major Players of 10 mL
Table 5. Global Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 6. Global Basiliximab Injection Sales Market Share by Type (2018-2023)
Table 7. Global Basiliximab Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Basiliximab Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Basiliximab Injection Sale Price by Type (2018-2023) & (US$/L)
Table 10. Global Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 11. Global Basiliximab Injection Sales Market Share by Application (2018-2023)
Table 12. Global Basiliximab Injection Revenue by Application (2018-2023)
Table 13. Global Basiliximab Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Basiliximab Injection Sale Price by Application (2018-2023) & (US$/L)
Table 15. Global Basiliximab Injection Sales by Company (2018-2023) & (KL)
Table 16. Global Basiliximab Injection Sales Market Share by Company (2018-2023)
Table 17. Global Basiliximab Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Basiliximab Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Basiliximab Injection Sale Price by Company (2018-2023) & (US$/L)
Table 20. Key Manufacturers Basiliximab Injection Producing Area Distribution and Sales Area
Table 21. Players Basiliximab Injection Products Offered
Table 22. Basiliximab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Basiliximab Injection Sales by Geographic Region (2018-2023) & (KL)
Table 26. Global Basiliximab Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Basiliximab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Basiliximab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Basiliximab Injection Sales by Country/Region (2018-2023) & (KL)
Table 30. Global Basiliximab Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Basiliximab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Basiliximab Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Basiliximab Injection Sales by Country (2018-2023) & (KL)
Table 34. Americas Basiliximab Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Basiliximab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Basiliximab Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 38. Americas Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 39. APAC Basiliximab Injection Sales by Region (2018-2023) & (KL)
Table 40. APAC Basiliximab Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Basiliximab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Basiliximab Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 44. APAC Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 45. Europe Basiliximab Injection Sales by Country (2018-2023) & (KL)
Table 46. Europe Basiliximab Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Basiliximab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Basiliximab Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 50. Europe Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 51. Middle East & Africa Basiliximab Injection Sales by Country (2018-2023) & (KL)
Table 52. Middle East & Africa Basiliximab Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Basiliximab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Basiliximab Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Basiliximab Injection Sales by Type (2018-2023) & (KL)
Table 56. Middle East & Africa Basiliximab Injection Sales by Application (2018-2023) & (KL)
Table 57. Key Market Drivers & Growth Opportunities of Basiliximab Injection
Table 58. Key Market Challenges & Risks of Basiliximab Injection
Table 59. Key Industry Trends of Basiliximab Injection
Table 60. Basiliximab Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Basiliximab Injection Distributors List
Table 63. Basiliximab Injection Customer List
Table 64. Global Basiliximab Injection Sales Forecast by Region (2024-2029) & (KL)
Table 65. Global Basiliximab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Basiliximab Injection Sales Forecast by Country (2024-2029) & (KL)
Table 67. Americas Basiliximab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Basiliximab Injection Sales Forecast by Region (2024-2029) & (KL)
Table 69. APAC Basiliximab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Basiliximab Injection Sales Forecast by Country (2024-2029) & (KL)
Table 71. Europe Basiliximab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Basiliximab Injection Sales Forecast by Country (2024-2029) & (KL)
Table 73. Middle East & Africa Basiliximab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Basiliximab Injection Sales Forecast by Type (2024-2029) & (KL)
Table 75. Global Basiliximab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Basiliximab Injection Sales Forecast by Application (2024-2029) & (KL)
Table 77. Global Basiliximab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis AG Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis AG Basiliximab Injection Product Portfolios and Specifications
Table 80. Novartis AG Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 81. Novartis AG Main Business
Table 82. Novartis AG Latest Developments
Table 83. Ryvis Pharma Basic Information, Basiliximab Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Ryvis Pharma Basiliximab Injection Product Portfolios and Specifications
Table 85. Ryvis Pharma Basiliximab Injection Sales (KL), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 86. Ryvis Pharma Main Business
Table 87. Ryvis Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Basiliximab Injection
Figure 2. Basiliximab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Basiliximab Injection Sales Growth Rate 2018-2029 (KL)
Figure 7. Global Basiliximab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Basiliximab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 20 mL
Figure 10. Product Picture of 10 mL
Figure 11. Global Basiliximab Injection Sales Market Share by Type in 2022
Figure 12. Global Basiliximab Injection Revenue Market Share by Type (2018-2023)
Figure 13. Basiliximab Injection Consumed in Adult Use
Figure 14. Global Basiliximab Injection Market: Adult Use (2018-2023) & (KL)
Figure 15. Basiliximab Injection Consumed in Pediatric Use
Figure 16. Global Basiliximab Injection Market: Pediatric Use (2018-2023) & (KL)
Figure 17. Global Basiliximab Injection Sales Market Share by Application (2022)
Figure 18. Global Basiliximab Injection Revenue Market Share by Application in 2022
Figure 19. Basiliximab Injection Sales Market by Company in 2022 (KL)
Figure 20. Global Basiliximab Injection Sales Market Share by Company in 2022
Figure 21. Basiliximab Injection Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Basiliximab Injection Revenue Market Share by Company in 2022
Figure 23. Global Basiliximab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Basiliximab Injection Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Basiliximab Injection Sales 2018-2023 (KL)
Figure 26. Americas Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 27. APAC Basiliximab Injection Sales 2018-2023 (KL)
Figure 28. APAC Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 29. Europe Basiliximab Injection Sales 2018-2023 (KL)
Figure 30. Europe Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Basiliximab Injection Sales 2018-2023 (KL)
Figure 32. Middle East & Africa Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 33. Americas Basiliximab Injection Sales Market Share by Country in 2022
Figure 34. Americas Basiliximab Injection Revenue Market Share by Country in 2022
Figure 35. Americas Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 36. Americas Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 37. United States Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Basiliximab Injection Sales Market Share by Region in 2022
Figure 42. APAC Basiliximab Injection Revenue Market Share by Regions in 2022
Figure 43. APAC Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 44. APAC Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 45. China Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Basiliximab Injection Sales Market Share by Country in 2022
Figure 53. Europe Basiliximab Injection Revenue Market Share by Country in 2022
Figure 54. Europe Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 55. Europe Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 56. Germany Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Basiliximab Injection Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Basiliximab Injection Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 65. Egypt Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Basiliximab Injection in 2022
Figure 71. Manufacturing Process Analysis of Basiliximab Injection
Figure 72. Industry Chain Structure of Basiliximab Injection
Figure 73. Channels of Distribution
Figure 74. Global Basiliximab Injection Sales Market Forecast by Region (2024-2029)
Figure 75. Global Basiliximab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Basiliximab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Basiliximab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Basiliximab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Basiliximab Injection Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Basiliximab Injection
Figure 2. Basiliximab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Basiliximab Injection Sales Growth Rate 2018-2029 (KL)
Figure 7. Global Basiliximab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Basiliximab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 20 mL
Figure 10. Product Picture of 10 mL
Figure 11. Global Basiliximab Injection Sales Market Share by Type in 2022
Figure 12. Global Basiliximab Injection Revenue Market Share by Type (2018-2023)
Figure 13. Basiliximab Injection Consumed in Adult Use
Figure 14. Global Basiliximab Injection Market: Adult Use (2018-2023) & (KL)
Figure 15. Basiliximab Injection Consumed in Pediatric Use
Figure 16. Global Basiliximab Injection Market: Pediatric Use (2018-2023) & (KL)
Figure 17. Global Basiliximab Injection Sales Market Share by Application (2022)
Figure 18. Global Basiliximab Injection Revenue Market Share by Application in 2022
Figure 19. Basiliximab Injection Sales Market by Company in 2022 (KL)
Figure 20. Global Basiliximab Injection Sales Market Share by Company in 2022
Figure 21. Basiliximab Injection Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Basiliximab Injection Revenue Market Share by Company in 2022
Figure 23. Global Basiliximab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Basiliximab Injection Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Basiliximab Injection Sales 2018-2023 (KL)
Figure 26. Americas Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 27. APAC Basiliximab Injection Sales 2018-2023 (KL)
Figure 28. APAC Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 29. Europe Basiliximab Injection Sales 2018-2023 (KL)
Figure 30. Europe Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Basiliximab Injection Sales 2018-2023 (KL)
Figure 32. Middle East & Africa Basiliximab Injection Revenue 2018-2023 ($ Millions)
Figure 33. Americas Basiliximab Injection Sales Market Share by Country in 2022
Figure 34. Americas Basiliximab Injection Revenue Market Share by Country in 2022
Figure 35. Americas Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 36. Americas Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 37. United States Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Basiliximab Injection Sales Market Share by Region in 2022
Figure 42. APAC Basiliximab Injection Revenue Market Share by Regions in 2022
Figure 43. APAC Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 44. APAC Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 45. China Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Basiliximab Injection Sales Market Share by Country in 2022
Figure 53. Europe Basiliximab Injection Revenue Market Share by Country in 2022
Figure 54. Europe Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 55. Europe Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 56. Germany Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Basiliximab Injection Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Basiliximab Injection Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Basiliximab Injection Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Basiliximab Injection Sales Market Share by Application (2018-2023)
Figure 65. Egypt Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Basiliximab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Basiliximab Injection in 2022
Figure 71. Manufacturing Process Analysis of Basiliximab Injection
Figure 72. Industry Chain Structure of Basiliximab Injection
Figure 73. Channels of Distribution
Figure 74. Global Basiliximab Injection Sales Market Forecast by Region (2024-2029)
Figure 75. Global Basiliximab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Basiliximab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Basiliximab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Basiliximab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Basiliximab Injection Revenue Market Share Forecast by Application (2024-2029)
